The tripeptide sequence Trp-Lys-Ser (WKS) is repeated three times in the extracellular ligand binding domain of human Tissue Factor (TF). Using site-directed mutagenesis, we replaced each of the WKS motifs in human TF by Arg-Lys-Gly (RKG), the least conserved replacement for the motif found in murine TF 
INTRODUCTION
Cellular initiation of coagulation is mediated by Tissue Factor (TF), a cell-surface receptor and functional cofactor for the plasma serine proteinase VIIa [1, 2] . There is no close sequence similarity between TF and other proteins, although structural similarity of the TF extracellular domain to the interferon yreceptors and, more distantly, to the cytokine receptor family of proteins, has been suggested [3, 4] . The sequence WKS was found three times in the mature human TF protein, a statistically improbable occurrence, and it was speculated that the tripeptide motif might have a functional significance [5] . Each of these motifs in human TF is encoded by a separate exon [6] , and all WKS motifs are localized in the TF extracellular domain, which provides critical protein-protein interactions for binding of the ligand VITa [7, 8] . The present study uses site-directed mutagenesis to evaluate the functional significance of this motif at position [14] [15] [16] (encoded by exon 2), 45-47 (encoded by exon 3), and 158-160 (encoded by exon 4) [6] . This approach indicates a structural importance of Trp14 in the first repeat and provides evidence that the third repeat of the tripeptide motif is associated with a functional site in the TF extracellular domain.
MATERIALS AND METHODS
Site-directed mutagenesis and expression of TF in eukaryotic cells The TF coding sequence inserted in the expression vector CDM8 [9, 10] was modified using oligonucleotide-directed mutagenesis as described by Kunkel [11] with the modifications as previously reported [12] . Typically, oligonucleotides were designed which introduced the desired amino acid substitution as well as generated or destroyed restriction-endonuclease cleavage sites. The mutations were confirmed by dideoxynucleotide sequencing with Sequenase (United States Biochemical). Chinesehamster ovary cells were transfected with mutated plasmid DNA using the calcium phosphate method [13] , followed by cell harvest after 72 h. Stable cell lines expressing certain TF mutants were generated and selected as described [12] .
Functional characterization of the TF mutants
Transfected cells were harvested after detachment with 10 mM-EDTA and were resuspended in a small volume after repeated washes in Tris-buffered saline (TBS; 20 mM-Tris/ 150 mM-NaCl, pH 7.4). Portions containing a defined number of cells were sedimented, followed by removal of the supernatant for storage at -70 'C. These cell pellets were either lysed with 2 % Triton X-100 in TBS for antigen determination by e.l.i.s.a. [7] using two monoclonal antibodies to non-overlapping epitopes [14] or with 15 mM-octyl /.-D-glucopyranoside for determination offunctional activity in a one-stage clotting assay, as previously described [15] . Flow cytometry to evaluate monoclonal-antibody epitope expression and Western-blot analysis to reveal TF protein from transient transfection experiments were performed as previously described [12] . [14] , suggesting spatial proximity of the epitope to a Factor VII interactive site. The second WKS motif may therefore be near to, but not an intrinsic part of, this Factor VII-interactive site.
RESULTS
Substitution of the W158KS motif by RKG resulted in an 86 %//, loss of functional activity ( Table 2 ). The mutant protein: (i) was expressed at high levels, (ii) exhibited a normal pattern of TF band microheterogeneity by Western blot, which is characteristic of normal glycosylation of TF [10] , and (iii) equivalently expressed all monoclonal-antibody epitopes (Fig. 1) . This is consistent with proper global folding of the protein, and suggests a functional importance of the W158KS motif in TF. We further addressed the functional defects of the first and third motifs by additional substitutions in the tripeptide motif as well as by replacing adjacent residues. There is evidence that residues adjacent to Trp'58 are functionally important. The Lys"59 -+ Ala substitution leads to loss of functional activity comparable with the Trp'58 -+ Arg substitution. No structural alteration was detected for TFA159 based on monoclonal-antibody epitope expression (Fig. 1) [18] . Since it is likely that the W158KS motif is at the surface of TF rather than buried in a hydrophobic core (see above), the amino group of Lys'59 may be one of the functionally critical lysine residues susceptible to chemical modification.
The functional site also extends proximally from Trp'58, as demonstrated by the functional importance of Tyr157. The Tyr157 --Ala mutant resulted in an 870 loss of specific activity.
There must be a critical role of the aromatic ring and only a minor contribution of the hydroxy group of Tyr 57, since the Tyr157 -. Phe replacement was fully functional. There could be structural importance for Tyr'57 to maintain local conformation by contribution to aromatic-aromatic interactions [19] , or the aromatic ring could contribute to the interaction with ligand in addition to the charged group of Lys159. The effect of the Trp'58 -. Arg substitutions may be explained by slight alterations of the side-chain orientation of the adjacent residues Lys'59 and Tyr'57, which may be interactive with the ligand Factor Vlla. Similarly to Ser 60, the side chain of Tyr'56 can be deleted by replacement with Ala without loss of function. This analysis therefore provides evidence for a functionally important sequence span from Tyr'57 to Lys'59, with two flanking residues which appear to be unnecessary for specific receptor cofactor function. Tyr157 and Lys159 are also found in the mouse TF sequence. The reported lower functional activity of mouse TF in human plasma [17] can therefore not be accounted for by the lack of the two critical interactive residues in mouse TF. However, the spatial relationship of these two residues will differ depending on whether they are embedded in the Tyr-Tyr-Trp-Lys-Ser (YYWKS) or the Thr-Tyr-Arg-Lys-Gly (TYRKG) sequence (Table 1) . The Trp158 to Arg substitution in human TF appears to introduce a slight perturbation of the Tyr157 and/or Lys159 side chains resulting in loss of specific function. Similarly, these two residues may be oriented in the murine sequence less favourably for the interaction with human Factor VII. Although not proved by the present results, these differences in the local conformation at the third WKS position due to exchange of Trp by Arg and Ser by Gly in the mouse sequence could account for the variations in procoagulant activity of the two species.
Whereas Trp'4 appears to be structurally important, no involvement of this residue, or of Lys"5, in the formation of the functional TF Factor VIIa complex could be demonstrated. Similarly, the non-conservative RKG substitution in the W45KS motif did not significantly affect functional activity. However, substitutions in the W158KS motif provided evidence for the participation of a WKS motif in a functional site in the Cterminus of the TF extracellular domain. Lys'59 of the WKS motif was identified as functionally important, and the functional significance of Tyr157 indicates involvement of adjacent residues. There are likely to be other residues which contribute to this functional site, but are not in a linear proximity to the tripeptide motif. The epitope of an inhibitory monoclonal antibody had been shown to have critical residues encoded by exon 4 and part of exon 5 [14] . In addition, covalent stabilization of carboxy disulphide loops in the TF extracellular domain is important for binding of Factor VII and function ofTF [12] . These independent approaches therefore provide convergent evidence for the functional role of the C-terminal half of the TF extracellular domain. Single amino acid residues are identified which mediate functional interactions and provide localization of an interactive site in TF important to formation of the TF * Factor VIla initiation complex on cells.
